NEK6 and breast carcinoma: This then provides the first evidence tentatively linking Nek6 to carcinogenesis and, together with the fact that overexpression of catalytically-inactive Nek6 reduces the growth rate of MDA-MB-231 human breast cancer cells [73], highlights Nek6 as a potential chemotherapeutic target.